| AD | Alzheimer’s disease |
| HMGB1 | High mobility group box 1 |
| DAMP | Damage-associated molecular pattern |
| APP | Amyloid precursor protein |
| PS1 | Presenilin 1 |
| Aβ | Amyloid-β |
| TLR | Toll-like receptor |
| RAGE | Receptor for Advanced Glycation End products |
| NLSs | Nuclear localization signals |
| CXCR4 | C-X-C motif chemokine receptor 4 |
| MARCKS | Myristoylated alanine-rich C-kinase substrate |
| MCI | Mild cognitive impairment |
| FTD | Frontotemporal Dementia |
| TREM2 | Triggering receptor expression on myeloid cells 2 |
| CSF | Cerebrospinal fluid |
| PrxI/II | Peroxiredoxins I and II |
| SIRT1 | Sirtuin1 |
| HAT | Histone acetyltransferase |
| HDAC | Histone deacetylase |
| NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 |
| CD11b | Cluster of Differentiation 11b |
| TIM-3 | T-cell Immunoglobulin and Mucin domain-containing protein 3 |
| SASP | Senescence-associated secretory phenotype |
| MMP-3 | Matrix Metalloproteinase-3 |
| ICM | Intra-cisterna magna |
| SOD2 | Superoxide Dismutase 2 |
| M-CSF | Macrophage colony-stimulating factor |
| NEP | Neprilysin |
| IDE | Insulin-degrading enzyme |
| tPA | Tissue-type plasminogen activator |
| AQP4 | Aquaporin-4 |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |